Higher prevalence of urogenital mycoplasmas in human immunodeficiency virus-positive patients as compared to patients with other sexually transmitted diseases

被引:0
|
作者
Cordova, CMM
Blanchard, A
Cunha, RAF
机构
[1] Univ Sao Paulo, Fac Ciencias Farmaceut, Lab Imunol Clin, BR-05508900 Sao Paulo, Brazil
[2] Inst Pasteur, Unite Oncol Virale, F-75724 Paris, France
关键词
Mycoplasma genitalium; M; fermentans; penetrans; HIV; STD; nongonococcal urethritis (NGU); PCR;
D O I
10.1002/1098-2825(2000)14:5<246::AID-JCLA8>3.0.CO;2-F
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
We determined the prevalence of three emergent urogenital mycoplasma species (M. fermentans, M. penetrans, and M. genitalium) in comparison to the most common species (RI. hominis and U. urealyticum). M. genitalium is probably the third most frequent agent of nongonococcal urethritis (NGU) in men. It has been suggested that M. fermentans and M. penetrans play a role in the development of AIDS. We analysed the urine and the urethral swab samples from 106 HIV-1 infected individuals (HIV group) and 110 HIV-negative patients with NGU (STD group) by using PCR and culture methods. M. genitalium was detected in 0.9% of the urine and in 1.9% of the urethral samples from the HIV group, compared to 9.1% found only in urethral swab samples from the STD group. M. fermentans was detected in 5.7% urethral swabs from the HIV group and in 0.9% from the STD group. M. penetrans was detected in 6.6% urine samples from the HIV group. M. hominis and U. urealyticum showed infection rates of 7.5 and 18.9% in the HIV group, and 0.9 and 13.6% in the STD group. Overall there was a higher prevalence of mycoplasmas in the HIV group than in the STD group, but the significance of these results remains unclear. (C) 2000 Wiley-Liss, Inc.
引用
收藏
页码:246 / 253
页数:8
相关论文
共 50 条
  • [31] The success of endosseous implants in human immunodeficiency virus-positive patients receiving antiretroviral therapy A pilot study
    Oliveira, Marcio A.
    Gallottini, Marina
    Pallos, Debora
    Maluf, Paulo S. Z.
    Jablonka, Fernando
    Ortega, Karem L.
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 2011, 142 (09): : 1010 - 1016
  • [32] Pharmacy Workers' Sexually Transmitted Diseases/Human Immunodeficiency Virus Knowledge in Fuzhou, China: Implications for Human Immunodeficiency Virus Testing, Treatment, and Prevention Strategies
    Wen, Yi
    Guan, Jihui
    Wu, Zunyou
    Li, Li
    Rotheram-Borus, Mary Jane
    Lin, Chunqing
    Detels, Roger
    SEXUALLY TRANSMITTED DISEASES, 2009, 36 (04) : 221 - 226
  • [33] A Review of the Use of Biological Agents in Human Immunodeficiency Virus Positive Patients With Rheumatological Diseases
    Attallah, Marline A.
    Jara, Maria Daniela Jarrin
    Gautam, Avneesh S.
    Peesapati, Venkata Sri Ramani
    Khan, Safeera
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (10)
  • [34] Ritonavir Use in Human Immunodeficiency Virus-Positive Surgical Patients Is Not Associated with an Increase in Postoperative Critical Respiratory Events
    Maher, Dermot P.
    Lee, Jacqueline
    Woo, Pauline
    Zhang, Xiao
    White, Paul F.
    Yumul, Roya
    Conte, Antonio Hernandez
    JOURNAL OF PAIN & PALLIATIVE CARE PHARMACOTHERAPY, 2016, 30 (01) : 25 - 30
  • [35] Clinically Significant Drug Interactions in Younger and Older Human Immunodeficiency Virus-Positive Patients Receiving Antiretroviral Therapy
    Yiu, Pannyun
    Nguyen, Nancy N.
    Holodniy, Mark
    PHARMACOTHERAPY, 2011, 31 (05): : 480 - 489
  • [36] Rifapentine for latent tuberculosis infection treatment in the general population and human immunodeficiency virus-positive patients: summary of evidence
    Vidal, Julia Souza
    Silva, Marcus Tolentino
    Sanchez, Mauro Niskier
    REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2015, 48 (05) : 507 - 513
  • [37] Clinically Significant Drug Interactions Among Human Immunodeficiency Virus-Positive Patients on Antiretroviral Therapy in an Outpatient Setting
    Monday, Lea M.
    Veltman, Jennifer
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 2018, 26 (05) : 279 - 282
  • [38] Identification of Cryptococcus antigen in human immunodeficiency virus-positive Turkish patients by using the Dynamiker® lateral flow assay
    Karaman, Evrim
    Ilkit, Macit
    Kuscu, Ferit
    MYCOSES, 2019, 62 (10) : 961 - 968
  • [39] Otoneurological findings in human immunodeficiency virus positive patients
    Teggi, R.
    Ceserani, N.
    Luce, F. Lira
    Lazzarin, A.
    Bussi, M.
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2008, 122 (12): : 1289 - 1294
  • [40] Hepatitis G virus infection in hepatitis C virus-positive patients co-infected or not with hepatitis B virus and/or human immunodeficiency virus
    Thiers, V
    Pol, S
    Persico, T
    Carnot, F
    Zylberberg, H
    Berthelot, P
    Brechot, C
    Nalpas, B
    JOURNAL OF VIRAL HEPATITIS, 1998, 5 (02) : 123 - 130